AI assistant
INVENTURUS KNOWLEDGE SOLUTIONS LIMITED — Earnings Release 2026
May 13, 2026
60278_rns_2026-05-13_ecbc3461-fc66-496b-b22f-4cb43b106925.pdf
Earnings Release
Open in viewerOpens in your device viewer
IKS HEALTH
May 13, 2026
BSE Limited
The Listing Department
Phiroze Jeejeebhoy Towers
25th Floor, Dalal Street
Fort, Mumbai 400 001
Maharashtra, India
BSE Scrip Code: 544309
National Stock Exchange of India Limited
The Listing Department
Exchange Plaza, Plot No. C/1, G Block,
Bandra Kurla Complex
Bandra (East), Mumbai 400051
Maharashtra, India
BSE Symbol: IKS
Dear Sir/Ma’am,
Sub: Press Release – Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2026.
Press Release in respect of Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2026, is enclosed herewith.
Request you to take it on record and disseminate the same on your website.
Thanking you.
Yours sincerely,
For Inventurus Knowledge Solutions Limited
Sameer S Chavan
Digitally signed by
Sameer S Chavan
Date: 2026.05.13
19:38:28 +05'30'
Sameer Chavan
Company Secretary and Compliance Officer
Membership No. F7211
Encl: As above
M/s. Inventurus Knowledge Solutions Limited
801, Building No. 5 & 6, 8th Floor, Mindspace Business Park (SEZ), Thane - Belapur Road, Airoli, Navi Mumbai - 400 708, Thane, Maharashtra, India. | Board: +91 22 3071 1100 | Fax: 91 22 6646 6879 | [email protected] | www.ikshealth.com
Registered Address: 801, Building No. 5 & 6, 8th Floor, Mindspace Business Park (SEZ), Thane - Belapur Road, Airoli, Navi Mumbai - 400 708, Thane, Maharashtra, India. CIN: L72200MH2006PLC337651
IKS HEALTH
PRESS RELEASE
Inventurus Knowledge Solutions (IKS Health) Reports Robust FY26 Financial Results with 20% Revenue Growth and 48% Surge in Profit After Tax
Mumbai, India | May 13, 2026: Inventurus Knowledge Solutions Limited (NSE: IKS), a leading technology-enabled healthcare solutions provider and care enablement platform for the US Healthcare industry, today announced its robust financial results for the fiscal year and quarter ended March 31, 2026. The company, widely recognized as IKS Health, reported an exceptional performance, driven by a 20% year-on-year (YoY) revenue growth and a significant 48% surge in Profit After Tax (PAT) for the full financial year 2026.
Key Financial Highlights: FY 2026
- Revenue at ₹31,938 million (20% YoY)
- PAT at ₹7,216 million (48% YoY)
- EBITDA at ₹10,913 million (38% YoY)
- Adjusted PAT at ₹8,087 million (47% YoY)
Consolidated Financial Highlights for the Financial Year 2025-26
| | FY2026
(INR mn) | FY2025
(INR mn) | FY26 Growth |
| --- | --- | --- | --- |
| Revenue | 31,938 | 26,640 | 19.9% |
| PAT | 7,216 | 4,861 | 48.4% |
| EBITDA | 10,913 | 7,911 | 38.0% |
| Adjusted PAT | 8,087 | 5,504 | 46.9% |
Key Financial Highlights: Q4 FY26
- Revenue growth in Q4 18% YoY in INR, 13% YoY in USD
- PAT up 39% growth YoY; 12% QoQ
- Q4 EBITDA up 33% YoY; 6.6% QoQ
IKS HEALTH
- Adjusted PAT up 38% YoY; 5% QoQ
Consolidated Financial Highlights for the Quarter ended March 31, 2026:
| Q4 FY 2026 (INR mn) | Q3 FY 2026 (INR mn) | Q4 FY 2025 (INR mn) | Growth | |
|---|---|---|---|---|
| Revenue | 8,577 | 8,150 | 7,240 | 18.5% YoY |
| PAT | 2,060 | 1,833 | 1,478 | 39.4% YoY |
| EBITDA | 3,002 | 2,816 | 2,262 | 32.7% YoY |
| Adjusted PAT | 2,269 | 2,154 | 1,646 | 37.9% YoY |
"Our performance this fiscal year underscores the deep value we bring to clinician enterprises as they navigate an increasingly complex US healthcare landscape. Ending the year with a strong 20% YoY revenue growth in FY 2026 is a testament to the scalability of our care enablement platform," said Sachin K. Gupta, Founder & CEO, IKS Health. "Our 'AI + Human' model is now the industry standard for sustainable growth, as proven by our expanding partnerships with top-tier health systems. By deploying autonomous engines and agentic AI like MyCareHub™, we are providing the clinical and financial intelligence needed to transform care delivery. We enter FY27 with the financial strength to accelerate this AI-driven momentum."
Nithya Balasubramanian, CFO, IKS Health said, "Our fiscal year concluded with exceptional operational discipline, reflected in our 38% YoY EBITDA growth and significant margin expansion. The 48% rise in PAT for the year demonstrates our ability to scale efficiently and deliver profitable growth through a resilient business model which leverages the latest technology and global delivery. With a strong balance sheet and robust cash flow generation, we are well-positioned to continue investing in our technology platform to drive long-term, sustainable value for our shareholders."
Business Highlights:
- AI Portfolio Expansion: Aquihired ThinkDTM, an AI-native digital services firm, integrating a specialized team of experts to accelerate the development of patient access solutions.
- Next-Gen Product Launches: Introduced two major Epic-integrated solutions available on the Epic Connection Hub:
- Autonomous RCM Coding Engine: An AI-driven solution achieving 95% accuracy, reducing denials through a blend of autonomous assignment and expert review.
IKS HEALTH
- MyCareHub™: An agentic AI "self-orchestrating" platform that uses multi-agent algorithms to automate and personalize patient engagement.
- Strategic AI Partnerships: Formed a collaboration with Certilytics to unify payer rules and provider workflows using agentic AI and human oversight.
- Market Expansion & Client Wins:
- Secured a multi-year, full-platform partnership with Holyoke Medical Center to drive financial stability through AI-led clinical and administrative solutions.
- Expanded the platform relationship with Mission Community Hospital to include development of advanced AI capabilities within the hospital environment to improve operational efficiencies.
- Expanded a major Revenue Cycle (RCM) and Value-Based Care (VBC) partnership with a Top 5 U.S. Health System, extending services into new regions and states.
Industry Recognition & Awards
- Recognition: ET Edge Best Organisations for Women 2026
- FE AICONIC Award: Best Use of AI in Healthcare & Lifesciences - for the IKS Health Virtual Care Assistant Solution
Safe Harbour
Certain statements in this release concerning our future growth prospects may be seen as forward-looking statements, which involve a number of risks and uncertainties that could cause the actuals to differ materially from such statements. It is not possible to undertake to update any such statement that may have been made from time to time.
About IKS Health
IKS Health reduces the administrative, clinical, and operational burdens that slow healthcare down, giving clinicians and care teams the freedom to focus on delivering exceptional care. Through its Care Enablement platform, IKS Health integrates AI, agentic workflows, and human expertise to create smarter operations, better outcomes, and financially sustainable growth across the care journey. Founded in 2006 and recognized by Black Book as the top provider of AI-driven RCM services, by KLAS for performance and client satisfaction, and by Google Cloud with the 2025 DORA Award for "Augmenting Human Expertise with AI," IKS Health partners with the largest health systems, physician groups, and specialty practices across the United States. Learn more at ikshealth.com.
IKS
HEALTH
Inventurus Knowledge Solutions Limited was listed on National Stock Exchange of India Limited (NSE) and BSE Limited (Bombay Stock Exchange) on December 19, 2024. {Scrip codes: NSE - IKS and BSE - S44309}
| MEDIA CONTACT - IKS HEALTH | INVESTOR RELATIONS CONTACT - IKS HEALTH |
|---|---|
| Sameer Arora | Saransh Mundra |
| Senior Vice President | Head - Investor Relations |
| [email protected] | [email protected] |
-XX-XX-XX-